Skip to:Content
|
Bottom
Cover image for Protein misfolding diseases: current and emerging principles and therapies
Title:
Protein misfolding diseases: current and emerging principles and therapies
Publication Information:
New Jersey, NJ : Wiley, 2010
Physical Description:
xxx, 1045 p. : ill. ; 25 cm.
ISBN:
9780471799283

Available:*

Library
Item Barcode
Call Number
Material Type
Item Category 1
Status
Searching...
30000010234055 RC632.P7 P763 2010 Open Access Book Book
Searching...

On Order

Summary

Summary

An increasingly aging population will add to the number of individuals suffering from amyloid. Protein Misfolding Diseases provides a systematic overview of the current and emerging therapies for these types of protein misfolding diseases, including Alzheimer's, Parkinson's, and Mad Cow. The book emphasizes therapeutics in an amyloid disease context to help students, faculty, scientific researchers, and doctors working with protein misfolding diseases bridge the gap between basic science and pharmaceutical applications to protein misfolding disease.


Author Notes

Marina Ramirez-Alvarado is an Assistant Professor of Biochemistry and Molecular Biology at the Mayo Clinic. Despite being a young investigator, she is already a world leader in the study of molecular determinants of light chain amyloidosis, a rare misfolding disease.
Jeffery W. Kelly is a Professor of Chemistry and Molecular and Experimental Medicine at the Scripps Research Institute. He is one of the leading authorities in the field of protein misfolding, with over 250 publications to his credit.
Christopher M. Dobson is a Professor in the Department of Chemistry at the University of Cambridge. Dr. Dobson is a leading researcher studying the structural and biochemical bases of protein misfolding diseases and has over 500 publications.


Table of Contents

R. John EllisVladimir N. UverskySilvia Campioni and Elodie Monsellier and Fabrizio ChitiJyoti D. Malhotra and Randal J. KaufmanKausik Chakraborty and Florian Georgescauld and Manajit Hayer-Hartl and F. Ulrich HartlEvan T. Powers and Frank A. FerroneMassimo StefaniMaria Kon and Ana Maria CuervoAndisheh Abedini and Ruchi Gupta and Peter Marek and Fanling Meng and Daniel P. Raleigh and Humeyra Taskent and Sylvia TraczPeter M. Tessier and Susan LindquistElise A. Kikis and Anat Ben-Zvi and Richard I. MorimotoJulide Bilen and Nancy M. BoniniKaren H. AsheDonald L. Price and Alena V. Savonenko and Tong Li and Michael K. Lee and Philip C. WongValerie L. Sim and Byron CaugheyRonald WetzelMarina Ramirez-Alvarado and Joel N. BuxbaumDavid P. Smith and Alison E. Ashcroft and Sheena E. RadfordDuane D. Winkler and Mercedes Prudencio and Celeste Karch and David R. Borchelt and P. John HartDavid A. Lomas and David H. PerlmutterWilliam E. Balch and Ineke Braakman and Jeff Brodsky and Raymond Frizzell and William Guggino and Gergely L. Lukacs and Christopher Penland and Harvey Pollard and William Skach and Eric Sorscher and Philip ThomasFang Li and Richard M. WeinshilboumTim EdmundsYongting Wang and Jonathan A. KingAndisheh Abedini and Daniel P. RaleighBlaine R. Roberts and Ashley I. BushRobert Kisilevsky and John AncsinSimon Kolstoe and Steve WoodPaul H. Axelsen and Hiroaki KomatsuJohanna C. Scheinost and Daniel P. Witter and Grant E. Boldt and Paul Wentworth, Jr.Ehud Cohen and Andrew DillinHarry LeVine, IIIMorie A. GertzJerry A. KatzmannTadato Ban and Yuji GotoParamita Chakrabarty and Pritam Das and Todd E. GoldeAngela Dispenzieri and Shaji KumarSteven R. Zeldenrust and Merrill D. BensonJulianna Tomlinson and Valerie Cullen and Michael G. SchlossmacherGennaro Esposito and Vittorio BellottiMireille DumoulinMaria Pennuto and Kenneth H. FischbeckMark A. FindeisJonathan WallZane Martin and Claudio SotoGregor P. Lotz and Paul J. MuchowskiSteven M. Johnson and R. Luke Wiseman and Natàlia Reixach and Johan F. Paulsson and Sungwook Choi and Evan T. Powers and Joel N. Buxbaum and Jeffery W. Kelly
Contributorsp. xi
Forewordp. xix
Prefacep. xxv
Acknowledgmentsp. xxvii
Introduction to the Wiley Series on Protein and Peptide Sciencep. xxix
Part I Principles of Protein Misfolding
1 Why Proteins Misfoldp. 3
2 Endoplasmic Reticulum Stress and Oxidative Stress: Mechanisms and Link to Diseasep. 21
3 Role of Molecular Chaperones in Protein Foldingp. 47
4 Kinetic Models for Protein Misfolding and Associationp. 73
5 Toxicity in Amyloid Diseasesp. 93
6 Autophagy: An Alternative Degradation Mechanism for Misfolded Proteinsp. 113
7 Role of Posttranslational Modifications in Amyloid Formationp. 131
8 Unraveling Molecular Mechanisms and Structures of Self-Perpetuating Prionsp. 145
9 Caenorhabditis elegans as a Model System to Study the Biology of Protein Aggregation and Toxicityp. 175
10 Using Drosophila to Reveal Insight into Protein Misfolding Diseasesp. 191
11 Animal Models to Study the Biology of Amyloid-ß Protein Misfolding in Alzheimer Diseasep. 213
Part II Protein Misfolding Disease: Gain-of-Function and Loss-of-Function Diseases
12 Alzheimer Disease: Protein Misfolding, Model Systems, and Experimental Therapeuticsp. 233
13 Prion Disease Therapy: Trials and Tribulationsp. 259
14 Misfolding and Aggregation in Huntington Disease and Other Expanded Polyglutamine Repeat Diseasesp. 305
15 Systemic Amyloidosesp. 325
16 Hemodialysis-Related Amyloidosisp. 347
17 Copper-Zinc Superoxide Dismutase, its Copper Chaperone, and Familial Amyotrophic Lateral Sclerosisp. 381
18 Alpha-1-Antitrypsin Deficiencyp. 403
19 Folding Biology of Cystic Fibrosis: A Consortium-based Approach to Diseasep. 425
20 Thiopurine S-Methyltransferase Pharmacogenomics: Protein Misfolding, Aggregation, and Degradationp. 453
21 Gaucher Diseasep. 469
22 Cataract as a Protein-Aggregation Diseasep. 487
23 Islet Amyloid Polypeptidep. 517
Part III Role of Accessory Molecules and Risk Factors
24 Role of Metals in Alzheimer Diseasep. 545
25 Why Study the Role of Heparan Sulfate in In Vivo Amyloidogenesis?p. 559
26 Serum Amyloid P Componentp. 571
27 Role of Oxidatively Stressed Lipids in Amyloid Formation and Toxicityp. 585
28 Role of Oxidative Stress in Protein Misfolding and/or Amyloid Formationp. 615
29 Aging and Aggregation-Mediated Proteotoxicityp. 631
Part IV Medical Aspects of Disease: Diagnosis and Current Therapies
30 Imaging of Misfolded Proteinsp. 647
31 Diagnosis of Systemic Amyloid Diseasesp. 673
32 Identification of Biomarkers for Diagnosis of Amyloid Diseases: Quantitative Free Light-Chain Assaysp. 689
33 Real-Time Observation of Amyloid-ß Fibril Growth by Total Internal Reflection Fluorescence Microscopyp. 699
34 Current and Future Therapies for Alzheimer Diseasep. 711
35 Current Therapies for Light-Chain Amyloidosisp. 775
36 Familial and Senile Amyloidosis Caused by Transthyretinp. 795
37 Identifying Targets in ¿-Synuclein Metabolism to Treat Parkinson Disease and Related Disordersp. 817
38 Emerging Molecular Targets in the Therapy of Dialysis-Related Amyloidosisp. 843
39 Familial Amyloidosis Caused by Lysozymep. 867
40 Therapeutic Prospects for Polyglutamine Diseasep. 887
Part V Approaches for New and Emerging Therapies
41 Chemistry and Biology of Amyloid Inhibitionp. 905
42 Immunotherapy in Secondary and Light-Chain Amyloidosisp. 917
43 Anti-Misfolding and Anti-Fibrillization Therapies for Protein Misfolding Disordersp. 933
44 Therapies Aimed at Controlling Gene Expression, Including Up-Regulating a Chaperone or Down-Regulating an Amyloidogenic Proteinp. 945
45 Understanding and Ameliorating the TTR Amyloidosesp. 967
Indexp. 1005
Go to:Top of Page